| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |